Search All Resources
Substance Use and Injecting Behaviors During and After Hepatitis C Treatment Among Persons Who Inject Drugs | March 22, 2023
Type: Past Presentation
Audience: Clinical
Program: Hepatitis C
Keywords: #cure #hcv #pwid #substance use
In this presentation, Kimberly Page, PhD, MPH, Professor of Epidemiology at The University of New Mexico, describes injection practices among people who inject drugs (PWID) before, during, and after HCV treatment with DAAs. Dr Page also examines whether sharing injecting ...
Date added: 03/20/23
Medications for Alcohol Use Disorder | March 15, 2023
In this presentation, Dr. Jasen Christensen, DO, discusses the FDA-approved and off-label medications for alcohol use disorder, shares the evidence supporting each medication and provides tangible ways to apply treatments to appropriate cases.
Date added: 03/15/23
NASH Update 2023 | March 1, 2023
Type: Past Presentation
Audience: Clinical
Program: Hepatitis C
Keywords: #aasld #fatty liver #hepatitis #liver #nafl #NAFLD #NASH
In this presentation, Dr. Richard Manch, MD, provides a comprehensive overview and update as it relates to Nonalcoholic Fatty Liver Disease (NAFLD) and particularly, Nonalcoholic Steatohepatitis (NASH). Furthermore, Dr. Manch provides an American Association for the Study of Liver Diseases ...
Date added: 03/1/23
Hepatitis B Medications | February 22, 2023
Type: Past Presentation
Audience: Clinical
Program: Hepatitis C
Keywords: #hbv #hbv treatment #hepatitis b
In this presentation, Dr. Paulina Deming, ECHO faculty member and Associate Professor of Pharmacy at the University of New Mexico Sciences Center, discusses the current recommended medications for HBV treatment. She then differentiates between the recommended therapies for HBV. Learn ...
Date added: 02/22/23
Lethal Means Safety Counseling | February 1, 2023
In this presentation, Dr. Jasen Christensen, DO, discusses the evidence supporting safety planning, shares how to find a template for an evidence-supported safety plan and provides tangible ways to utilize lethal means safety questions.
Date added: 02/1/23
Cirrhotic Ascites | December 7, 2022
Type: Past Presentation
Audience: Clinical
Program: Hepatitis C
Keywords: #ascites #cirrhosis #hcv #management #paracentesis
In this presentation Richard Manch, MD, discusses management of patients with ascites. He discusses the indications and contraindications for paracentesis, initial laboratory investigation of ascitic fluid, the core elements for treatment of ascites (including sodium restriction, appropriate use of diuretics, ...
Date added: 12/7/22
Evaluation of Infectious Diseases in People with SUD | November 9, 2022
Type: Past Presentation
Audience: Clinical
Program: Hepatitis C
Keywords: #hcv #infectious disease #mat #pharmacotherapy #prevention #Screening #substance use #SUD #treatment
In this presentation Jorge Mera, MD, discusses evaluation of infectious diseases for people with substance use disorders. He discusses a clinical case, the syndemic of HIV, HCV, STIs and SUDs, the intersection between infectious disease and substance use disorder and the ...
Date added: 11/14/22
New Data: Buprenorphine and Benzodiazepine Overdose Risk | November 2, 2022
Type: Past Presentation
Program: Hepatitis C
Keywords: #benzo #benzodiazepine #bup #buprenorphine #clonidine #literature #od #overdose #suboxone
In this presentation, Dr. Jasen Christensen, DO, discusses how the addition of buprenorphine changes overdose risk, explains the affect of buprenorphine on risk for benzodiazepine overdose and describes the use of Clonidine in MOUD treatment.
Date added: 11/2/22
Language of Addiction | October 19, 2022
Type: Past Presentation
Audience: Clinical
Program: Hepatitis C
Keywords: #language #mat #MOUD #non-stigmatizing language #OUD #Recovery #substance use disorders #SUD
Dr. Karla Thornton, Professor of Infectious Diseases at the University of New Mexico Health Sciences Center, speaks about the importance of using non-stigmatizing language in substance use and shares the language recommended by the Office of National Drug Control Policy.
Date added: 10/19/22
Pre-Exposure Prophylaxis (PrEP) for HIV Prevention | October 26, 2022
Type: Past Presentation Training
Audience: Clinical
Program: Hepatitis C Ending the Epidemics in Indian Country ECHO Program
Keywords: #hiv #pre-exposure prophylaxis #prep
In this presentation, Dr. Jorge Mera, Indian Country ECHO Medical Director and Director of Infectious Diseases at Cherokee Nation, discusses HIV PrEP, the evidence on effectiveness, monitoring, and best practices, including remote provision of PrEP care services.
Date added: 10/11/22